GSK replaces China chief amid corruption scandal

Thu Jul 25, 2013 1:58pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

By Ben Hirschler

LONDON (Reuters) - GlaxoSmithKline has appointed one of its top European executives as the new head of operations in China, amid a corruption scandal there that has rocked Britain's biggest drug maker.

Herve Gisserot, senior vice president for Europe, will take over as general manager from Mark Reilly, who will remain with the company as a senior member of the management team, a spokesman said on Thursday.

Reilly, currently in Britain, will continue to help lead GSK's response to the Chinese government's bribery investigation - but the spokesman declined to say whether he would travel back to China.

Reilly has been working at GSK's headquarters on the outskirts of London since arriving from China in early July for what people familiar with the situation said at the time were routine meetings.

"From what we understand and have been told by the authorities there are no allegations of wrongdoing against Mark (Reilly)," the spokesman said.

Gisserot will transition over the coming weeks into his new role, where his prime focus will be to ensure that GSK's China business continues to operate as smoothly as possible.

FINANCE HEAD FREE TO TRAVEL

At the same time, travel restrictions on GSK's finance head for China, Steve Nechelput, which had prevented him from leaving the country, are believed to have been lifted, the spokesman added.   Continued...

 
A flag (L) bearing the logo of GlaxoSmithKline (GSK) flutters next to a Chinese national flag outside a GlaxoSmithKline office building in Shanghai July 12, 2013. REUTERS/Aly Song